|
Real-time Estimate
Cboe BZX
18:26:15 12/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.170 USD | +1.46% |
|
-16.57% | +205.93% |
| Market Cap | 295M 255M 239M 218M 410M 28.1B 417M 2.8B 1.1B 14.06B 1.11B 1.08B 46.92B | P/E 2026 * |
-1.92x | P/E 2027 * | -2.2x |
|---|---|---|---|---|---|
| Enterprise Value | 90.02M 78.01M 73.03M 66.64M 125M 8.59B 128M 856M 336M 4.3B 338M 331M 14.34B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.52x |
| Free-Float |
77.31% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | +1.46% | ||
| 1 week | -16.57% | ||
| Current month | -12.87% | ||
| 1 month | -10.61% | ||
| 3 months | -3.50% | ||
| 6 months | +76.50% | ||
| Current year | +205.93% |
| 1 week | 4.01 |  | 5.15 |
| 1 month | 4.01 | | 5.58 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.21 | | 6.95 |
| 3 years | 1.01 | | 29.03 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 13/11/2024 |
| Director of Finance/CFO | - | 13/11/2024 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 13/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 16/05/2022 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 09/02/2021 |
Jan Skvarka
BRD | Director/Board Member | 59 | 12/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/02/26 | Sell | Chief Technology Officer | 3,297 | 0.0046% | ||
| 06/02/26 | Sell | Chief Executive Officer | 8,755 | 0.0121% | ||
| 06/02/26 | Sell | Chief Financial Officer | 40,224 | 0.0557% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.46% | -16.57% | +192.91% | -85.38% | 295M | |
| -0.70% | +13.34% | +75.61% | +103.83% | 70.51B | |
| +0.91% | +0.99% | +36.86% | +65.39% | 54.05B | |
| +1.69% | +36.25% | +10.59% | +505.00% | 28.95B | |
| -0.61% | +12.51% | +54.60% | +7.40% | 24.05B | |
| -0.16% | +1.08% | -16.05% | -13.27% | 23.31B | |
| +9.77% | +20.16% | +260.17% | +472.38% | 18.67B | |
| +1.58% | +6.82% | +46.03% | -20.28% | 18.37B | |
| 0.00% | +7.46% | +30.95% | +623.97% | 16.1B | |
| -0.23% | -9.92% | +34.58% | +137.45% | 12.72B | |
| Average | +1.39% | +6.20% | +72.62% | +179.65% | 26.7B | |
| Weighted average by Cap. | +0.92% | +9.18% | +57.17% | +170.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 18.2M 15.77M 14.76M 13.47M 25.35M 1.74B 25.78M 173M 67.83M 869M 68.33M 66.84M 2.9B |
| Net income | -165M -143M -134M -122M -230M -15.77B -234M -1.57B -616M -7.89B -621M -607M -26.33B | -172M -149M -140M -127M -240M -16.42B -244M -1.64B -642M -8.22B -646M -632M -27.41B |
| Net Debt | -205M -177M -166M -151M -285M -19.51B -290M -1.95B -762M -9.77B -768M -751M -32.58B | -139M -121M -113M -103M -194M -13.3B -198M -1.33B -520M -6.66B -524M -512M -22.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | $4.130 | +0.49% | 46,013 |
| 11/08/26 | $4.110 | -0.96% | 401,838 |
| 10/08/26 | $4.150 | -1.66% | 824,758 |
| 07/08/26 | $4.220 | -15.60% | 1,578,420 |
| 06/08/26 | $5.000 | +1.01% | 701,819 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
